Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 259, pseudogene (RNU6-259P) is catalogued as a pseudogene in the human genome. Pseudogenes are non-functional sequences derived from functional genes, often through duplication or retrotransposition events. RNU6-259P has no demonstrated function or protein product; its sequence resembles that of U6 small nuclear RNA—a crucial component of the spliceosome—but is not transcribed into a functional RNA molecule. While some pseudogenes exert regulatory effects in disease contexts (e.g., by acting as miRNA decoys or influencing gene expression), there are no current reports linking RNU6-259P to any biological process, mechanism, or clinical application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 259, pseudogene (RNU6-259P).